AptaBio Therapeutics Market Cap

AptaBio Therapeutics has a market cap or net worth of 210.48 billion as of June 6, 2025. Its market cap has increased by 55.76% in one year.

Market Cap

210.48B

Enterprise Value

193.53B

Revenue

3.11B

Ranking

n/a

PE Ratio

n/a

Stock Price

7,830.00

Market Cap Chart

Since June 12, 2019, AptaBio Therapeutics's market cap has decreased from 423.30B to 210.48B, a decrease of -50.28%. That is a compound annual growth rate of -11.02%.

Market Cap History

Date	Market Cap	% Change
Jun 5, 2025	210.48B	22.92%
Dec 30, 2024	171.23B	-15.15%
Dec 28, 2023	201.80B	-15.02%
Dec 29, 2022	237.48B	-71.24%
Dec 30, 2021	825.71B	46.50%
Dec 30, 2020	563.64B	49.70%
Dec 30, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	72.53T
Celltrion	34.68T
ALTEOGEN	19.69T
Yuhan	7,778.15B
SK Biopharmaceuticals	7,079.52B
HLB Co., Ltd.	6,860.00B
PharmaResearch	4,976.64B
LigaChem Biosciences	3,893.48B

Market Cap Rankings